Skip to content
Sign in

IBBQ · NASDAQ · ETF

Invesco Nasdaq Biotechnology ETF (IBBQ) Price, Holdings & Fees

$714.68−0.41%−$2.96End-of-day price as of Oct 9, 2026

Invesco Nasdaq Biotechnology ETF (IBBQ) closed at $714.68 on Oct 9, 2026, down 0.41% from the previous close of $717.64.

Share price, past year

1Y +21.69%

52-week range $585.08 – $718.34. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$714.68
Sep 30, 2026$705.85
Aug 31, 2026$704.24
Jul 31, 2026$661.88
Jun 30, 2026$660.99
May 29, 2026$655.95
Apr 30, 2026$632.21
Mar 31, 2026$601.93
Feb 27, 2026$586.20
Jan 30, 2026$630.96
Dec 31, 2025$630.83
Nov 28, 2025$649.73
Oct 31, 2025$614.84

Key statistics

Expense ratio
0.19%
as of Dec 31, 2025
Net assets
$67.4M
as of May 31, 2026
Holdings
261
as of May 31, 2026
52-week range
$585.08 – $718.34

Invesco Nasdaq Biotechnology ETF's expense ratio is 0.19%: $19.00 a year on $10,000 invested.

Holdings

Invesco Nasdaq Biotechnology ETF held 261 investments worth $67.37M as of May 31, 2026. Its largest holding was Invesco Private Prime Fund, at 14.20% of the fund.

Invesco Nasdaq Biotechnology ETF largest holdings by share of net assets
#Holding% of fundValue
1Invesco Private Prime Fund14.20%$9.57M
2Gilead Sciences, Inc.7.39%$4.98M
3Vertex Pharmaceuticals Inc.7.38%$4.97M
4Amgen Inc.7.10%$4.79M
5Invesco Private Government Fund5.48%$3.69M
6Regeneron Pharmaceuticals, Inc.5.08%$3.42M
7Alnylam Pharmaceuticals, Inc.3.19%$2.15M
8Revolution Medicines, Inc.2.48%$1.67M
9Biogen Inc.2.29%$1.54M
10Illumina, Inc.1.98%$1.34M
11United Therapeutics Corp.1.94%$1.31M
12Royalty Pharma PLC1.90%$1.28M
13argenx SE1.89%$1.27M
14Insmed Inc.1.83%$1.24M
15Roivant Sciences Ltd.1.71%$1.15M
16Incyte Corp.1.53%$1.03M
17Viatris Inc.1.49%$1.00M
18Moderna, Inc.1.48%$999.15K
19Guardant Health, Inc.1.35%$911.98K
20Neurocrine Biosciences, Inc.1.26%$851.81K
21Jazz Pharmaceuticals PLC1.16%$780.42K
22Ascendis Pharma A/S1.10%$739.79K
23Summit Therapeutics Inc.1.08%$729.12K
24Exelixis, Inc.1.04%$702.83K
25BridgeBio Pharma, Inc.1.02%$688.64K

Top 25 of 261 holdings, as of May 31, 2026. Percentages are of the fund's net assets.

What the fund owns

Invesco Nasdaq Biotechnology ETF holdings by asset type
Asset type% of fund
Stocks99.87%
Cash and short-term investments19.69%
Invesco Nasdaq Biotechnology ETF holdings by country, largest 10
Country% of fund
United States103.75%
United Kingdom2.73%
Netherlands2.49%
Ireland1.88%
Bermuda1.71%
France1.50%
Denmark1.23%
Switzerland1.18%
Canada0.93%
Germany0.87%

Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.

Monthly total returns

Over the 3 months to May 31, 2026, Invesco Nasdaq Biotechnology ETF's total return was −0.70%, as reported to the SEC.

Invesco Nasdaq Biotechnology ETF monthly total returns
MonthTotal return
May 31, 2026+2.26%
Apr 30, 2026+0.41%
Mar 31, 2026−3.30%

The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.

Fund profile

Name
Invesco Nasdaq Biotechnology ETF
Ticker
IBBQ
Exchange
NASDAQ
Fund type
ETF
Trust
Invesco Exchange-Traded Fund Trust II
SEC series ID
S000072469
SEC CIK
0001378872
Fractional shares
Yes

Recent SEC filings

Shareholder reports and prospectuses are filed by Invesco Exchange-Traded Fund Trust II, the trust behind Invesco Nasdaq Biotechnology ETF, and cover all of its funds.

Frequently asked questions

What is IBBQ's price?

Invesco Nasdaq Biotechnology ETF (IBBQ) closed at $714.68 on Oct 9, 2026, down 0.41% from the previous close of $717.64.

What is IBBQ's expense ratio?

Invesco Nasdaq Biotechnology ETF's expense ratio is 0.19%: $19.00 a year on $10,000 invested.

What does IBBQ hold?

Invesco Nasdaq Biotechnology ETF held 261 investments worth $67.37M as of May 31, 2026. Its largest holding was Invesco Private Prime Fund, at 14.20% of the fund. Its five largest holdings were Invesco Private Prime Fund, Gilead Sciences, Inc., Vertex Pharmaceuticals Inc., Amgen Inc., Invesco Private Government Fund.

How has IBBQ performed?

Over the 3 months to May 31, 2026, Invesco Nasdaq Biotechnology ETF's total return was −0.70%, as reported to the SEC.

Sources and methodology

Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of May 31, 2026 (filed Jul 28, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Dec 31, 2025. Prices are generated sample data for development. Data sources and disclosures